Related Experiment Video
Updated: Jun 4, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Testing Compounds for Antiviral Activity in Cell Cultures Infected with HIV
Methods in Molecular Medicine
|February 19, 2011
Summary
This study outlines methods for antiviral drug discovery against HIV. It details cell line maintenance, sample preparation, and assays for evaluating compound efficacy and toxicity in a standard laboratory setting.
Area of Science:
- Virology
- Drug Discovery
- Cell Biology
Background:
- Human Immunodeficiency Virus (HIV) remains a significant global health challenge, necessitating continuous research into effective antiviral therapies.
- Developing novel antiviral compounds requires robust and reproducible experimental methodologies for efficacy and toxicity screening.
Purpose of the Study:
- To describe standardized laboratory procedures for identifying potential antiviral compounds against HIV.
- To detail methods for assessing both the antiviral activity and cytotoxicity of candidate compounds.
Main Methods:
- Maintenance of lymphoblastoid cell lines and preparation of peripheral blood mononuclear cells (PMMCs).
- Determination of HIV stock infectivity and performance of antiviral assays using acutely and chronically infected cells.
- Assessment of compound toxicity through (14)C uptake measurements.
Main Results:
- The described protocols enable the evaluation of approximately 10 compounds per 96-well p24 enzyme-linked immunosorbent assay (ELISA) plate.
- These methods are suitable for a single researcher in a Category 3 containment laboratory.
Conclusions:
- The presented procedures provide a comprehensive framework for antiviral drug screening against HIV.
- These assays facilitate the efficient evaluation of novel compounds for their therapeutic potential and safety profile.
